TIS 0.00% 0.0¢ tissue therapies limited

I'd argue that the takeup and oversubscription of entitlements...

  1. 2,026 Posts.
    lightbulb Created with Sketch. 47
    I'd argue that the takeup and oversubscription of entitlements in the recent placement negated a lot of this statement don't you think?
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.